Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage

prnewswire.com
NVS

Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage

prnewswire.com
NVS

Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight

prnewswire.com
PFE ABBV RMD GSK AZN BNTX INCY IOVA RGEN MRK LLY IBIO GILD AMGN JNJ NVS RIGL BIIB

Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)

globenewswire.com
NVS

Global Smart Inhalers Market to Witness Robust CAGR Growth Through 2030, Driven by Technological Innovation and Digital Health

globenewswire.com
AZN NVS GSK

Long-Acting Drugs Market to Reach US$ 13.3 Billion by 2033 Expands Amid Advances in Sustained Drug Delivery and Chronic Disease Management - Persistence Market Research

prnewswire.com
LLY JNJ NVS AZN

Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight

prnewswire.com
JNJ SNY NVS INCY

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer

globenewswire.com
MRNA NUVL PFE LLY NVS

Kinaset Therapeutics Appoints Daniel G. Welch as Board Chair and David Lubner as Independent Director and Audit Committee Chair

businesswire.com
ULTA CRSP GILD PFE NVS REGN UCB LLY BIIB ARCL

IgA Nephropathy Clinical Trial Space Intensifies with 25+ Companies in Active Development | DelveInsight

globenewswire.com
NVS VRTX BIIB VTRS AZN IONS TAK ARWR BHVN NVO LLY LXRX XRTX REGN FMS MDT AMPH DRCT BMRC MAZE